IBDEI0EY ; ; 09-AUG-2016
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;MAY 12, 2016
 Q:'DIFQR(358.3)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,99) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.3,18895,0)
 ;;=E66.01^^55^780^38
 ;;^UTILITY(U,$J,358.3,18895,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,18895,1,3,0)
 ;;=3^Morbid Obesity
 ;;^UTILITY(U,$J,358.3,18895,1,4,0)
 ;;=4^E66.01
 ;;^UTILITY(U,$J,358.3,18895,2)
 ;;=^5002826
 ;;^UTILITY(U,$J,358.3,18896,0)
 ;;=E66.8^^55^780^42
 ;;^UTILITY(U,$J,358.3,18896,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,18896,1,3,0)
 ;;=3^Obesity NEC
 ;;^UTILITY(U,$J,358.3,18896,1,4,0)
 ;;=4^E66.8
 ;;^UTILITY(U,$J,358.3,18896,2)
 ;;=^5002831
 ;;^UTILITY(U,$J,358.3,18897,0)
 ;;=E66.9^^55^780^43
 ;;^UTILITY(U,$J,358.3,18897,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,18897,1,3,0)
 ;;=3^Obesity,Unspec
 ;;^UTILITY(U,$J,358.3,18897,1,4,0)
 ;;=4^E66.9
 ;;^UTILITY(U,$J,358.3,18897,2)
 ;;=^5002832
 ;;^UTILITY(U,$J,358.3,18898,0)
 ;;=E74.39^^55^780^35
 ;;^UTILITY(U,$J,358.3,18898,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,18898,1,3,0)
 ;;=3^Intestinal Carbohydrate Absorption Disorder NEC
 ;;^UTILITY(U,$J,358.3,18898,1,4,0)
 ;;=4^E74.39
 ;;^UTILITY(U,$J,358.3,18898,2)
 ;;=^5002928
 ;;^UTILITY(U,$J,358.3,18899,0)
 ;;=E83.30^^55^780^46
 ;;^UTILITY(U,$J,358.3,18899,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,18899,1,3,0)
 ;;=3^Phosphorus Metabolism Disorder,Unspec
 ;;^UTILITY(U,$J,358.3,18899,1,4,0)
 ;;=4^E83.30
 ;;^UTILITY(U,$J,358.3,18899,2)
 ;;=^5002997
 ;;^UTILITY(U,$J,358.3,18900,0)
 ;;=E83.51^^55^780^28
 ;;^UTILITY(U,$J,358.3,18900,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,18900,1,3,0)
 ;;=3^Hypocalcemia
 ;;^UTILITY(U,$J,358.3,18900,1,4,0)
 ;;=4^E83.51
 ;;^UTILITY(U,$J,358.3,18900,2)
 ;;=^60542
 ;;^UTILITY(U,$J,358.3,18901,0)
 ;;=E83.52^^55^780^26
 ;;^UTILITY(U,$J,358.3,18901,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,18901,1,3,0)
 ;;=3^Hypercalcemia
 ;;^UTILITY(U,$J,358.3,18901,1,4,0)
 ;;=4^E83.52
 ;;^UTILITY(U,$J,358.3,18901,2)
 ;;=^59932
 ;;^UTILITY(U,$J,358.3,18902,0)
 ;;=E87.5^^55^780^27
 ;;^UTILITY(U,$J,358.3,18902,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,18902,1,3,0)
 ;;=3^Hyperkalemia
 ;;^UTILITY(U,$J,358.3,18902,1,4,0)
 ;;=4^E87.5
 ;;^UTILITY(U,$J,358.3,18902,2)
 ;;=^60041
 ;;^UTILITY(U,$J,358.3,18903,0)
 ;;=E89.2^^55^780^48
 ;;^UTILITY(U,$J,358.3,18903,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,18903,1,3,0)
 ;;=3^PostProcedural Hypoparathyroidism
 ;;^UTILITY(U,$J,358.3,18903,1,4,0)
 ;;=4^E89.2
 ;;^UTILITY(U,$J,358.3,18903,2)
 ;;=^5003037
 ;;^UTILITY(U,$J,358.3,18904,0)
 ;;=E89.6^^55^780^47
 ;;^UTILITY(U,$J,358.3,18904,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,18904,1,3,0)
 ;;=3^PostProcedural Adrenocortical Hypofunction
 ;;^UTILITY(U,$J,358.3,18904,1,4,0)
 ;;=4^E89.6
 ;;^UTILITY(U,$J,358.3,18904,2)
 ;;=^5003042
 ;;^UTILITY(U,$J,358.3,18905,0)
 ;;=L68.0^^55^780^25
 ;;^UTILITY(U,$J,358.3,18905,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,18905,1,3,0)
 ;;=3^Hirsutism
 ;;^UTILITY(U,$J,358.3,18905,1,4,0)
 ;;=4^L68.0
 ;;^UTILITY(U,$J,358.3,18905,2)
 ;;=^5009262
 ;;^UTILITY(U,$J,358.3,18906,0)
 ;;=M80.00XA^^55^780^2
 ;;^UTILITY(U,$J,358.3,18906,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,18906,1,3,0)
 ;;=3^Age-Related Osteoporosis w/ Fx,Unspec Site,Init Encntr
 ;;^UTILITY(U,$J,358.3,18906,1,4,0)
 ;;=4^M80.00XA
 ;;^UTILITY(U,$J,358.3,18906,2)
 ;;=^5013363
 ;;^UTILITY(U,$J,358.3,18907,0)
 ;;=M81.0^^55^780^3
 ;;^UTILITY(U,$J,358.3,18907,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,18907,1,3,0)
 ;;=3^Age-Related Osteoporosis w/o Fx
 ;;^UTILITY(U,$J,358.3,18907,1,4,0)
 ;;=4^M81.0
 ;;^UTILITY(U,$J,358.3,18907,2)
 ;;=^5013555
 ;;^UTILITY(U,$J,358.3,18908,0)
 ;;=M85.80^^55^780^44
 ;;^UTILITY(U,$J,358.3,18908,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,18908,1,3,0)
 ;;=3^Osteopenia,Unspec Site
 ;;^UTILITY(U,$J,358.3,18908,1,4,0)
 ;;=4^M85.80
 ;;^UTILITY(U,$J,358.3,18908,2)
 ;;=^5014473
 ;;^UTILITY(U,$J,358.3,18909,0)
 ;;=N62.^^55^780^24
 ;;^UTILITY(U,$J,358.3,18909,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,18909,1,3,0)
 ;;=3^Gynecomastia
 ;;^UTILITY(U,$J,358.3,18909,1,4,0)
 ;;=4^N62.
 ;;^UTILITY(U,$J,358.3,18909,2)
 ;;=^5015790
 ;;^UTILITY(U,$J,358.3,18910,0)
 ;;=E10.43^^55^780^6
 ;;^UTILITY(U,$J,358.3,18910,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,18910,1,3,0)
 ;;=3^DM Type 1 w/ Diabetic Autonomic Polyneuropathy
 ;;^UTILITY(U,$J,358.3,18910,1,4,0)
 ;;=4^E10.43
 ;;^UTILITY(U,$J,358.3,18910,2)
 ;;=^5002607
 ;;^UTILITY(U,$J,358.3,18911,0)
 ;;=E10.59^^55^780^4
 ;;^UTILITY(U,$J,358.3,18911,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,18911,1,3,0)
 ;;=3^DM Type 1 w/ Circulatory Complications
 ;;^UTILITY(U,$J,358.3,18911,1,4,0)
 ;;=4^E10.59
 ;;^UTILITY(U,$J,358.3,18911,2)
 ;;=^5002612
 ;;^UTILITY(U,$J,358.3,18912,0)
 ;;=E10.618^^55^780^5
 ;;^UTILITY(U,$J,358.3,18912,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,18912,1,3,0)
 ;;=3^DM Type 1 w/ Diabetic Arthropathy
 ;;^UTILITY(U,$J,358.3,18912,1,4,0)
 ;;=4^E10.618
 ;;^UTILITY(U,$J,358.3,18912,2)
 ;;=^5002614
 ;;^UTILITY(U,$J,358.3,18913,0)
 ;;=E10.621^^55^780^7
 ;;^UTILITY(U,$J,358.3,18913,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,18913,1,3,0)
 ;;=3^DM Type 1 w/ Diabetic Foot Ulcer
 ;;^UTILITY(U,$J,358.3,18913,1,4,0)
 ;;=4^E10.621
 ;;^UTILITY(U,$J,358.3,18913,2)
 ;;=^5002616
 ;;^UTILITY(U,$J,358.3,18914,0)
 ;;=E10.622^^55^780^11
 ;;^UTILITY(U,$J,358.3,18914,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,18914,1,3,0)
 ;;=3^DM Type 1 w/ Skin Ulcer
 ;;^UTILITY(U,$J,358.3,18914,1,4,0)
 ;;=4^E10.622
 ;;^UTILITY(U,$J,358.3,18914,2)
 ;;=^5002617
 ;;^UTILITY(U,$J,358.3,18915,0)
 ;;=E10.65^^55^780^10
 ;;^UTILITY(U,$J,358.3,18915,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,18915,1,3,0)
 ;;=3^DM Type 1 w/ Hyperglycermia
 ;;^UTILITY(U,$J,358.3,18915,1,4,0)
 ;;=4^E10.65
 ;;^UTILITY(U,$J,358.3,18915,2)
 ;;=^5002623
 ;;^UTILITY(U,$J,358.3,18916,0)
 ;;=E10.39^^55^780^9
 ;;^UTILITY(U,$J,358.3,18916,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,18916,1,3,0)
 ;;=3^DM Type 1 w/ Diabetic Ophthalmic Complications NEC
 ;;^UTILITY(U,$J,358.3,18916,1,4,0)
 ;;=4^E10.39
 ;;^UTILITY(U,$J,358.3,18916,2)
 ;;=^5002603
 ;;^UTILITY(U,$J,358.3,18917,0)
 ;;=E66.3^^55^780^45
 ;;^UTILITY(U,$J,358.3,18917,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,18917,1,3,0)
 ;;=3^Overweight
 ;;^UTILITY(U,$J,358.3,18917,1,4,0)
 ;;=4^E66.3
 ;;^UTILITY(U,$J,358.3,18917,2)
 ;;=^5002830
 ;;^UTILITY(U,$J,358.3,18918,0)
 ;;=E89.1^^55^780^49
 ;;^UTILITY(U,$J,358.3,18918,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,18918,1,3,0)
 ;;=3^Postprocedural Hypoinsulinemia
 ;;^UTILITY(U,$J,358.3,18918,1,4,0)
 ;;=4^E89.1
 ;;^UTILITY(U,$J,358.3,18918,2)
 ;;=^5003036
 ;;^UTILITY(U,$J,358.3,18919,0)
 ;;=H40.9^^55^781^9
 ;;^UTILITY(U,$J,358.3,18919,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,18919,1,3,0)
 ;;=3^Glaucoma,Unspec
 ;;^UTILITY(U,$J,358.3,18919,1,4,0)
 ;;=4^H40.9
 ;;^UTILITY(U,$J,358.3,18919,2)
 ;;=^5005931
 ;;^UTILITY(U,$J,358.3,18920,0)
 ;;=H26.9^^55^781^5
 ;;^UTILITY(U,$J,358.3,18920,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,18920,1,3,0)
 ;;=3^Cataract,Unspec
 ;;^UTILITY(U,$J,358.3,18920,1,4,0)
 ;;=4^H26.9
 ;;^UTILITY(U,$J,358.3,18920,2)
 ;;=^5005363
 ;;^UTILITY(U,$J,358.3,18921,0)
 ;;=H10.9^^55^781^8
 ;;^UTILITY(U,$J,358.3,18921,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,18921,1,3,0)
 ;;=3^Conjunctivitis,Unspec
 ;;^UTILITY(U,$J,358.3,18921,1,4,0)
 ;;=4^H10.9
 ;;^UTILITY(U,$J,358.3,18921,2)
 ;;=^5004716
 ;;^UTILITY(U,$J,358.3,18922,0)
 ;;=H11.32^^55^781^6
 ;;^UTILITY(U,$J,358.3,18922,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,18922,1,3,0)
 ;;=3^Conjunctival Hemorrhage,Left Eye
 ;;^UTILITY(U,$J,358.3,18922,1,4,0)
 ;;=4^H11.32
 ;;^UTILITY(U,$J,358.3,18922,2)
 ;;=^5004783
 ;;^UTILITY(U,$J,358.3,18923,0)
 ;;=H11.31^^55^781^7
 ;;^UTILITY(U,$J,358.3,18923,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,18923,1,3,0)
 ;;=3^Conjunctival Hemorrhage,Right Eye
 ;;^UTILITY(U,$J,358.3,18923,1,4,0)
 ;;=4^H11.31
 ;;^UTILITY(U,$J,358.3,18923,2)
 ;;=^5004782
 ;;^UTILITY(U,$J,358.3,18924,0)
 ;;=H01.002^^55^781^3
 ;;^UTILITY(U,$J,358.3,18924,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,18924,1,3,0)
 ;;=3^Blepharitis Unspec,Right Lower Eyelid
 ;;^UTILITY(U,$J,358.3,18924,1,4,0)
 ;;=4^H01.002
 ;;^UTILITY(U,$J,358.3,18924,2)
 ;;=^5004239
 ;;^UTILITY(U,$J,358.3,18925,0)
 ;;=H01.004^^55^781^2
 ;;^UTILITY(U,$J,358.3,18925,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,18925,1,3,0)
 ;;=3^Blepharitis Unspec,Left Upper Eyelid
 ;;^UTILITY(U,$J,358.3,18925,1,4,0)
 ;;=4^H01.004
 ;;^UTILITY(U,$J,358.3,18925,2)
 ;;=^5004241
 ;;^UTILITY(U,$J,358.3,18926,0)
 ;;=H01.005^^55^781^1
 ;;^UTILITY(U,$J,358.3,18926,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,18926,1,3,0)
 ;;=3^Blepharitis Unspec,Left Lower Eyelid
 ;;^UTILITY(U,$J,358.3,18926,1,4,0)
 ;;=4^H01.005
 ;;^UTILITY(U,$J,358.3,18926,2)
 ;;=^5133380
 ;;^UTILITY(U,$J,358.3,18927,0)
 ;;=H01.001^^55^781^4
 ;;^UTILITY(U,$J,358.3,18927,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,18927,1,3,0)
 ;;=3^Blepharitis Unspec,Right Upper Eyelid
 ;;^UTILITY(U,$J,358.3,18927,1,4,0)
 ;;=4^H01.001
 ;;^UTILITY(U,$J,358.3,18927,2)
 ;;=^5004238
 ;;^UTILITY(U,$J,358.3,18928,0)
 ;;=H57.13^^55^781^10
 ;;^UTILITY(U,$J,358.3,18928,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,18928,1,3,0)
 ;;=3^Ocular Pain,Bilateral
 ;;^UTILITY(U,$J,358.3,18928,1,4,0)
 ;;=4^H57.13
 ;;^UTILITY(U,$J,358.3,18928,2)
 ;;=^5006384
 ;;^UTILITY(U,$J,358.3,18929,0)
 ;;=H57.12^^55^781^11
 ;;^UTILITY(U,$J,358.3,18929,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,18929,1,3,0)
 ;;=3^Ocular Pain,Left Eye
 ;;^UTILITY(U,$J,358.3,18929,1,4,0)
 ;;=4^H57.12
 ;;^UTILITY(U,$J,358.3,18929,2)
 ;;=^5006383
 ;;^UTILITY(U,$J,358.3,18930,0)
 ;;=H57.11^^55^781^12
 ;;^UTILITY(U,$J,358.3,18930,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,18930,1,3,0)
 ;;=3^Ocular Pain,Right Eye
 ;;^UTILITY(U,$J,358.3,18930,1,4,0)
 ;;=4^H57.11
 ;;^UTILITY(U,$J,358.3,18930,2)
 ;;=^5006382
 ;;^UTILITY(U,$J,358.3,18931,0)
 ;;=S05.02XA^^55^782^3
 ;;^UTILITY(U,$J,358.3,18931,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,18931,1,3,0)
 ;;=3^Inj Conjunctiva/Corneal Abrasion w/o FB,Left Eye,Init
